XML 59 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Accounting
9 Months Ended
Sep. 30, 2014
Fair Value Disclosures [Abstract]  
Fair Value Accounting
Note 10 - Fair Value Accounting
Synovus carries various assets and liabilities at fair value based on the fair value accounting guidance under ASC 820 and ASC 825. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an “exit price”) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.
Fair Value Hierarchy
Synovus determines the fair value of its financial instruments based on the fair value hierarchy established under ASC 820-10, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the financial instrument's fair value measurement in its entirety. There are three levels of inputs that may be used to measure fair value. The three levels of inputs of the valuation hierarchy are defined below:
Level 1
Quoted prices (unadjusted) in active markets for identical assets and liabilities for the instrument or security to be valued. Level 1 assets include marketable equity securities as well as U.S. Treasury securities that are highly liquid and are actively traded in over-the-counter markets.
Level 2
Observable inputs other than Level 1 quoted prices, such as quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active or model-based valuation techniques for which all significant assumptions are derived principally from or corroborated by observable market data. Level 2 assets and liabilities include debt securities with quoted prices that are traded less frequently than exchange-traded instruments and derivative contracts whose value is determined by using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data. U.S. Government sponsored agency securities, mortgage-backed securities issued by U.S. Government sponsored enterprises and agencies, obligations of states and municipalities, CMOs issued by U.S. Government sponsored enterprises, and mortgage loans held-for-sale are generally included in this category. Certain private equity investments that invest in publicly traded companies are also considered Level 2 assets.
Level 3
Unobservable inputs that are supported by little, if any, market activity for the asset or liability. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow models and similar techniques, and may also include the use of market prices of assets or liabilities that are not directly comparable to the subject asset or liability. These methods of valuation may result in a significant portion of the fair value being derived from unobservable assumptions that reflect Synovus' own estimates for assumptions that market participants would use in pricing the asset or liability. This category primarily includes collateral-dependent impaired loans, other real estate, and certain private equity investments.
See Note 16 "Fair Value Accounting" to the consolidated financial statements of Synovus' 2013 Form 10-K for a description of valuation methodologies for assets and liabilities measured at fair value on a recurring and non-recurring basis.



Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table presents all financial instruments measured at fair value on a recurring basis as of September 30, 2014 and December 31, 2013, according to the valuation hierarchy included in ASC 820-10. For equity and debt securities, class was determined based on the nature and risks of the investments.
 
September 30, 2014
(in thousands)
Level 1
 
Level 2
 
Level 3
 
Total Assets and Liabilities at Fair Value
Assets
 
 
 
 
 
 
 
Trading securities:
 
 
 
 
 
 
 
Mortgage-backed securities issued by U.S. Government agencies
$

 
3,502

 

 
3,502

  Collateralized mortgage obligations issued by
  U.S. Government sponsored enterprises    

 
3,677

 

 
3,677

  State and municipal securities

 

 

 

  All other mortgage-backed
  securities    

 
4,174

 

 
4,174

Other investments
97

 
1,255

 

 
1,352

Total trading securities
$
97

 
12,608

 

 
12,705

Mortgage loans held for sale

 
72,333

 

 
72,333

Investment securities available for sale:
 
 
 
 
 
 
 
U.S. Treasury securities
42,668

 

 

 
42,668

U.S. Government agency securities

 
27,469

 

 
27,469

Securities issued by U.S. Government sponsored enterprises

 
82,327

 

 
82,327

Mortgage-backed securities issued by U.S. Government agencies

 
177,395

 

 
177,395

Mortgage-backed securities issued by U.S. Government sponsored enterprises

 
2,316,608

 

 
2,316,608

Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises

 
373,459

 

 
373,459

State and municipal securities

 
5,301

 

 
5,301

Equity securities
6,357

 

 

 
6,357

 Other investments(1)    
2,006

 
14,882

 
1,785

 
18,673

Total investment securities available for sale
$
51,031

 
2,997,441

 
1,785

 
3,050,257

Private equity investments

 
1,094

 
27,232

 
28,326

Mutual funds held in Rabbi Trusts
10,817

 

 

 
10,817

Derivative assets:
 
 
 
 
 
 
 
Interest rate contracts

 
30,184

 

 
30,184

Mortgage derivatives(2)

 
1,138

 

 
1,138

Total derivative assets
$

 
31,322

 

 
31,322

Liabilities
 
 
 
 
 
 
 
Trading account liabilities

 
6,264

 

 
6,264

Salary stock units
728

 

 

 
728

Derivative liabilities:
 
 
 
 
 
 
 
Interest rate contracts

 
30,689

 

 
30,689

Mortgage derivatives(2)

 
320

 

 
320

Visa derivative

 

 
4,021

 
4,021

Total derivative liabilities
$

 
31,009

 
4,021

 
35,030

 
 
 
 
 
 
 
 
 
December 31, 2013
(in thousands)
Level 1
 
Level 2
 
Level 3
 
Total Assets and Liabilities at Fair Value
Assets
 
 
 
 
 
 
 
Trading securities:
 
 
 
 
 
 
 
Collateralized mortgage obligations issued by U.S. Government sponsored enterprises

 
2,465

 

 
2,465

State and municipal securities

 
429

 

 
429

All other mortgage-backed securities

 
968

 

 
968

Other investments

 
2,251

 

 
2,251

Total trading securities
$

 
6,113

 

 
6,113

Mortgage loans held for sale

 
45,384

 

 
45,384

Investment securities available for sale:
 
 
 
 
 
 
 
     U.S. Treasury securities
17,791

 

 

 
17,791

U.S. Government agency securities

 
34,641

 

 
34,641

Securities issued by U.S. Government sponsored enterprises

 
113,745

 

 
113,745

Mortgage-backed securities issued by U.S. Government agencies

 
195,117

 

 
195,117

Mortgage-backed securities issued by U.S. Government sponsored enterprises

 
2,421,360

 

 
2,421,360

Collateralized mortgage obligations issued by U.S. Government agencies or sponsored enterprises

 
398,540

 

 
398,540

State and municipal securities

 
6,889

 

 
6,889

Equity securities
6,956

 

 
628

 
7,584

 Other investments(1)    
1,969

 

 
1,722

 
3,691

Total investment securities available for sale
$
26,716

 
3,170,292

 
2,350

 
3,199,358

Private equity investments

 
1,615

 
27,745

 
29,360

Mutual funds held in Rabbi Trusts
11,246

 

 

 
11,246

Derivative assets:
 
 
 
 
 
 
 
Interest rate contracts

 
38,482

 

 
38,482

Mortgage derivatives(2)

 
1,522

 

 
1,522

Total derivative assets
$

 
40,004

 

 
40,004

Liabilities
 
 
 
 
 
 
 
Trading account liabilities

 
1,763

 

 
1,763

Salary stock units
1,764

 

 

 
1,764

Derivative liabilities:
 
 
 
 
 
 
 
Interest rate contracts

 
39,436

 

 
39,436

Visa derivative

 

 
2,706

 
2,706

Total derivative liabilities
$

 
39,436

 
2,706

 
42,142

 
 
 
 
 
 
 
 
(1) Based on an analysis of the nature and risks of these investments, Synovus has determined that presenting these investments as a single asset class is appropriate.
(2) Mortgage derivatives consist of customer interest rate lock commitments that relate to the potential origination of mortgage loans, which would be classified as held for sale and forward loan sales commitments with third party investors.

Fair Value Option
Synovus has elected the fair value option for mortgage loans held for sale primarily to ease the operational burdens required to maintain hedge accounting for these loans. Synovus is still able to achieve effective economic hedges on mortgage loans held for sale without the operational time and expense needed to manage a hedge accounting program.
The following table summarizes the difference between the fair value and the unpaid principal balance of mortgage loans held for sale measured at fair value and the changes in fair value of these loans. Mortgage loans held for sale are initially measured at fair value with subsequent changes in fair value recognized in earnings. Changes in fair value were recorded as a component of mortgage banking income in the consolidated statements of income. An immaterial portion of these changes in fair value was attributable to changes in instrument-specific credit risk.
Changes in Fair Value Included in Net Income
 
 
 
 
 
 
 
 
For the Nine Months Ended September 30,
 
For the Three Months Ended September 30,
(in thousands)
2014
 
2013
 
2014
 
2013
Mortgage loans held for sale
$969
 
(3,838
)
 
(813
)
 
4,092

 
 
 
 
 
 
 
 

Mortgage Loans Held for Sale
 
(in thousands)
As of September 30, 2014
 
As of December 31, 2013
Fair value
$
72,333

 
45,384

Unpaid principal balance
70,924

 
44,943

Fair value less aggregate unpaid principal balance
$
1,409

 
441

 
 
 
 

Changes in Level 3 Fair Value Measurements
As noted above, Synovus uses significant unobservable inputs (Level 3) in determining the fair value of assets and liabilities classified as Level 3 in the fair value hierarchy. The table below includes a roll-forward of the amounts on the consolidated balance sheet for the nine and three months ended September 30, 2014 and 2013 (including the change in fair value), for financial instruments of a material nature that are classified by Synovus within Level 3 of the fair value hierarchy and are measured at fair value on a recurring basis. Transfers between fair value levels are recognized at the end of the reporting period in which the associated changes in inputs occur. During the first nine months of 2014 and 2013, Synovus did not have any material transfers between levels in the fair value hierarchy.
 
Nine Months Ended September 30,
 
2014
 
2013
(in thousands)
Investment Securities Available for Sale
 
 Private Equity Investments
 
Other Derivative
Contracts, Net
 
Investment Securities Available for Sale
 
 Private Equity Investments
 
Other Derivative
Contracts, Net
Beginning balance, January 1,
$
2,350

 
27,745

 
(2,706
)
 
$3,178
 
30,708

 
(2,956
)
Total gains (losses) realized/unrealized:
 
 
 
 
 
 
 
 
 
 
 
Included in earnings*    
(88
)
 
(513
)
 
(2,731
)
 

 
(856
)
 
(801
)
Unrealized gains (losses) included in other comprehensive income
63

 

 

 
401

 

 

Purchases

 




 

 

 

Sales

 

 

 

 

 

Issuances

 

 

 

 

 

Settlements
(540
)
 

 
1,416

 

 

 
1,252

Amortization of discount/premium

 

 

 

 

 

Transfers in and/or out of Level 3

 

 

 

 

 

Ending balance, September 30,
$
1,785

 
27,232

 
(4,021
)
 
3,579

 
29,852

 
(2,505
)
Total net gains (losses) for the nine months included in earnings attributable to the change in unrealized gains (losses) relating to assets and liabilities still held at September 30,
$
(88
)
 
(513
)
 
(2,731
)
 

 
(856
)
 
(801
)
 
 
 
 
 
 
 
 
 
 
 
 
* Included in earnings as a component of non-interest income (expense).

 
Three Months Ended September 30,
 
2014
 
2013
(in thousands)
Investment Securities Available for Sale
 
 Private Equity Investments
 
Other Derivative
Contracts, Net
 
Investment Securities Available for Sale
 
 Private Equity Investments
 
Other Derivative
Contracts, Net
Beginning balance, July 1,
$
1,866

 
27,376

 
(2,438
)
 
3,454

 
29,568

 
(2,977
)
Total gains (losses) realized/unrealized:
 
 
 
 
 
 
 
 
 
 
 
Included in earnings*    

 
(144
)
 
(1,979
)
 

 
284

 

Unrealized gains (losses) included in other comprehensive income
(81
)
 

 

 
125

 

 

Purchases

 

 

 

 

 

Sales

 

 

 

 

 

Issuances

 

 

 

 

 

Settlements

 

 
396

 

 

 
472

Amortization of discount/premium

 

 

 

 

 

Transfers in and/or out of Level 3

 

 

 

 

 

Ending balance, September 30,
$
1,785

 
27,232

 
(4,021
)
 
3,579

 
29,852

 
(2,505
)
Total net gains (losses) for the three months included in earnings attributable to the change in unrealized gains (losses) relating to assets and liabilities still held at September 30,
$

 
(144
)
 
(1,979
)
 

 
284

 

 
 
 
 
 
 
 
 
 
 
 
 
* Included in earnings as a component of non-interest income (expense).

Assets Measured at Fair Value on a Non-recurring Basis
From time to time, certain assets may be recorded at fair value on a non-recurring basis. These non-recurring fair value adjustments typically are a result of the application of lower of cost or fair value accounting or a write-down occurring during the period. For example, if the fair value of an asset in these categories falls below its cost basis, it is considered to be at fair value at the end of the period of the adjustment. The following table presents assets measured at fair value on a non-recurring basis as of the dates indicated for which there was a fair value adjustment during the period, according to the valuation hierarchy included in ASC 820-10.


September 30, 2014
 
December 31, 2013
(in thousands)
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
Impaired loans*
$

 

 
37,790

 
37,790

 

 

 
170,693

 
170,693

Other loans held for sale

 

 
338

 
338

 

 

 
9,670

 
9,670

Other real estate




25,928


25,928

 

 

 
50,070

 
50,070

Other assets held for sale
$

 

 
7,744

 
7,744

 

 

 
4,945

 
4,945

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


The following table presents fair value adjustments recognized for the nine and three months ended September 30, 2014 and 2013 for the assets measured at fair value on a non-recurring basis.
 
Nine Months Ended September 30,
 
Three Months Ended September 30,
(in thousands)
2014
 
2013
 
2014
 
2013
Impaired loans*
$
20,661

 
27,624

 
$
9,380

 
4,630

Other loans held for sale
285

 
2,844

 
285

 
2,833

Other real estate
7,343

 
5,919

 
4,114

 
1,406

Other assets held for sale
$
7,608

 
246

 
$
100

 
76

 
 
 
 
 
 
 
 

* Impaired loans that are collateral-dependent.

Quantitative Information about Level 3 Fair Value Measurements
The tables below provide an overview of the valuation techniques and significant unobservable inputs used in those techniques to measure financial instruments that are classified within Level 3 of the valuation hierarchy. The range of sensitivities that management utilized in its fair value calculations is deemed acceptable in the industry with respect to the identified financial instruments. The tables below present both the total balance as of the dates indicated for assets measured at fair value on a recurring basis and the assets measured at fair value on a non-recurring basis for which there was a fair value adjustment during the period, according to the valuation hierarchy included in ASC 820-10.
September 30, 2014
(dollars in thousands)
 
Level 3 Fair Value
 
Valuation Technique
Significant Unobservable Input
Range
(Weighted Average)(1)
Assets measured at fair
value on a recurring basis
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment Securities Available for Sale:
 
 
 
 
 
 
  Other Investments:
 
 
 
 
 
 
 
 
 
 
 
 
 
Trust preferred securities
 
1,785

 
Discounted cash flow analysis
Credit spread embedded in discount rate
450-550 bps (500 bps)
 
 
 
 
 
 
 
Private equity investments
 
27,232

 
Individual analysis of each investee company
Multiple factors, including but not limited to, current operations, financial condition, cash flows, evaluation of business management and financial plans, and recently executed financing transactions related to the investee companies
N/A
 
 
 
 
 
 
 
Visa derivative liability
 
4,021

 
Internal valuation
Multiple factors, including but not limited to, management's estimate of the timing and amount of the Covered Litigation settlement, and the resulting payments due to the counterparty under the terms of the contract.
N/A
 
 
 
 
 
 
 
September 30, 2014
(dollars in thousands)
 
Level 3 Fair Value
 
Valuation Technique
Significant Unobservable Input
Range
(Weighted Average)(1)
Assets measured at fair
value on a non-recurring basis
 
 
 
 
 
 
Collateral dependent impaired loans
 
$
37,790

 
Third party appraised value of collateral less estimated selling costs
Discount to appraised value (2)
Estimated selling costs
0% - 100% (48%)
0% - 10% (7%)
 
 
 
 
 
 
 
Other loans held for sale
 
338

 
Third party appraised value of collateral less estimated selling costs
Discount to appraised value (2)
Estimated selling costs
0% - 23% (23%)
0% - 10% (7%)
 
 
 
 
 
 
 
Other real estate
 
25,928

 
Third party appraised value of collateral less estimated selling costs
Discount to appraised value (2)
Estimated selling costs
0% - 38% (16%)
0% - 10% (7%)
 
 
 
 
 
 
 
Other assets held for sale
 
7,744

 
Third party appraised value of collateral less estimated selling costs or BOV
Discount to appraised value (2)
Estimated selling costs
0%-100% (69%)
0%-10% (10%)
 
 
 
 
 
 
 
(1) The range represents management's best estimate of the high and low of the value that would be assigned to a particular input. For assets measured at fair value on a non-recurring basis, the weighted average is the measure of central tendencies; it is not the value that management is using for the asset or liability.
(2) Synovus also makes adjustments to the values of the assets listed above for various reasons, including age of the appraisal, information known by management about the property, such as occupancy rates, changes to the physical conditions of the property, and other factors.



December 31, 2013
(dollars in thousands)
 
Level 3 Fair Value
 
Valuation Technique
Significant Unobservable Input
Range (Weighted Average)(1)
Assets measured at fair
value on a recurring basis
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment Securities Available for Sale:
 
 
 
 
 
 
Equity securities
 
$
628

 
Individual analysis of each investment
Multiple data points, including, but not limited to evaluation of past and projected business performance
N/A(3)
 
 
 
 
 
 
 
  Other Investments:
 
 
 
 
 
 
 
 
 
 
 
 
 
Trust preferred securities
 
1,722

 
Discounted cash flow analysis
Credit spread embedded in discount rate
400-480 bps (441 bps)
 
 
 
 
 
 
 
Private equity investments
 
27,745

 
Individual analysis of each investee company
Multiple factors, including but not limited to, current operations, financial condition, cash flows, evaluation of business management and financial plans, and recently executed company transactions related to the investee companies
N/A
 
 
 
 
 
 
 
Visa derivative liability
 
2,706

 
Internal valuation
Multiple factors, including but not limited to, management's estimate of the timing and amount of the Covered Litigation settlement, and the resulting payments due to the counterparty under the terms of the contract.
N/A
 
 
 
 
 
 
 
 
December 31, 2013
(dollars in thousands)
 
Level 3 Fair Value
 
Valuation Technique
Significant Unobservable Input
Range
(Weighted Average)(1)
Assets measured at fair
value on a non-recurring basis
 
 
 
 
 
 
Collateral dependent impaired loans
 
$
170,693

 
Third party appraised value of collateral less estimated selling costs
Discount to appraised value (2)
Estimated selling costs
0%-65% (25%)
0%-10% (7%)
 
 
 
 
 
 
 
Other loans held for sale
 
9,670

 
Third party appraised value of collateral less estimated selling costs
Discount to appraised value (2)
Estimated selling costs
0%-12% (4%)
0%-10% (7%)
 
 
 
 
 
 
 
Other real estate
 
50,070

 
Third party appraised value of collateral less estimated selling costs
Discount to appraised value (2)
Estimated selling costs
0%-7% (2%)
0%-10% (7%)
 
 
 
 
 
 
 
Other assets held for sale
 
4,945

 
Third party appraised value of collateral less estimated selling costs or BOV
Discount to appraised value (2)
Estimated selling costs
5%-36% (20%)
0%-10% (7%)
 
 
 
 
 
 
 
(1) The range represents management's best estimate of the high and low of the value that would be assigned to a particular input. For assets measured at fair value on a non-recurring basis, the weighted average is the measure of central tendencies; it is not the value that management is using for the asset or liability.
(2) Synovus also makes adjustments to the values of the assets listed above for various reasons, including age of the appraisal, information known by management about the property, such as occupancy rates, changes to the physical conditions of the property, and other factors.
(3) The range has not been disclosed due to the wide range of possible values given the methodology used.


Sensitivity Analysis of Level 3 Unobservable Inputs Measured on a Recurring Basis
Included in the fair value estimates of financial instruments carried at fair value on the consolidated balance sheet are those estimated in full or in part using valuation techniques based on assumptions that are not supported by observable market prices, rates, or other inputs. Unobservable inputs are assessed carefully, considering the current economic environment and market conditions. However, by their very nature, unobservable inputs imply a degree of uncertainty in their determination, because they are supported by little, if any, market activity for the related asset or liability.
Investment Securities Available for Sale
For the trust preferred securities in Level 3 assets, raising the credit spread, and raising the discount for lack of liquidity assumptions will result in a lower fair value measurement.
Private Equity Investments
In the absence of quoted market prices, inherent lack of liquidity, and the long-term nature of private equity investments, significant judgment is required to value these investments. The significant unobservable inputs used in the fair value measurement of private equity investments include current operations, financial condition, and cash flows, comparables and private sales, when available; and recently executed financing transactions related to investee companies. Significant increases or decreases in any of these inputs in isolation would result in a significantly lower or higher fair value measurement.
Visa Derivative Liability
The fair value of the Visa derivative contract is determined based on management's estimate of the timing and amount of the Covered Litigation settlement, and the resulting payments due to the counterparty under the terms of the contract. Significant increases (decreases) in any of these inputs in isolation could result in a significantly higher (lower) valuation of the Visa derivative liability.
Fair Value of Financial Instruments
The following table presents the carrying and fair values of financial instruments at September 30, 2014 and December 31, 2013. The fair value represents management’s best estimates based on a range of methodologies and assumptions. For financial instruments that are not recorded at fair value on the balance sheet, such as loans, interest bearing deposits (including brokered deposits), and long-term debt, the amounts disclosed in the notes should not be considered an estimate of the amount that would be realized if all such financial instruments were to be settled immediately. See Note 16 "Fair Value Accounting" to the consolidated financial statements of Synovus' 2013 Form 10-K for a description of valuation methodologies for assets and liabilities measured at fair value on a recurring and non-recurring basis and financial instruments that are not recorded at fair value on the balance sheet.
















The carrying and estimated fair values of financial instruments, as well as the level within the fair value hierarchy, as of September 30, 2014 and December 31, 2013 are as follows:
 
September 30, 2014

(in thousands)
Carrying Value
 
Estimated Fair Value
 
Level 1
 
Level 2
 
Level 3
Financial assets
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
386,402

 
386,402

 
386,402

 

 

Interest bearing funds with Federal Reserve Bank
750,446

 
750,446

 
750,446

 

 

Interest earning deposits with banks
13,612

 
13,612

 
13,612

 

 

Federal funds sold and securities purchased under resale agreements
70,918

 
70,918

 
70,918

 

 

Trading account assets
12,705

 
12,705

 
97

 
12,608

 

Mortgage loans held for sale
72,333

 
72,333

 

 
72,333

 

Other loans held for sale
338

 
338

 

 

 
338

Investment securities available for sale
3,050,257

 
3,050,257

 
51,031

 
2,997,441

 
1,785

Private equity investments
28,326

 
28,326

 

 
1,094

 
27,232

Mutual funds held in Rabbi Trusts
10,817

 
10,817

 
10,817

 

 

Loans, net of deferred fees and costs
20,588,566

 
20,334,382

 

 

 
20,334,382

Derivative assets
31,322

 
31,322

 

 
31,322

 

Financial liabilities
 
 
 
 
 
 
 
 
 
Trading account liabilities
6,264

 
6,264

 

 
6,264

 

Non-interest bearing deposits
5,813,809

 
5,813,809

 

 
5,813,809

 

Interest bearing deposits
15,175,972

 
15,177,126

 

 
15,177,126

 

Federal funds purchased and securities sold under repurchase agreements
107,160

 
107,160

 
107,160

 

 

Salary stock units
728

 
728

 
728

 

 

Long-term debt
2,130,934

 
2,185,455

 

 
2,185,455

 

Derivative liabilities
$
35,030

 
35,030

 

 
31,009

 
4,021

 
 
 
 
 
 
 
 
 
 
 
December 31, 2013

(in thousands)
Carrying Value
 
Estimated Fair Value
 
Level 1
 
Level 2
 
Level 3
Financial assets
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
469,630

 
469,630

 
469,630

 

 

Interest bearing funds with Federal Reserve Bank
644,528

 
644,528

 
644,528

 

 

Interest earning deposits with banks
24,325

 
24,325

 
24,325

 

 

Federal funds sold and securities purchased under resale agreements
80,975

 
80,975

 
80,975

 

 

Trading account assets
6,113

 
6,113

 

 
6,113

 

Mortgage loans held for sale
45,384

 
45,384

 

 
45,384

 

Other loans held for sale
10,685

 
10,685

 

 

 
10,685

Investment securities available for sale
3,199,358

 
3,199,358

 
26,716

 
3,170,292

 
2,350

Private equity investments
29,360

 
29,360

 

 
1,615

 
27,745

Mutual funds held in Rabbi Trusts
11,246

 
11,246

 
11,246

 

 

Loans, net of deferred fees and costs
20,057,798

 
19,763,708

 

 

 
19,763,708

Derivative assets
40,004

 
40,004

 

 
40,004

 

Financial liabilities
 
 
 
 
 
 
 
 
 
Trading account liabilities
1,763

 
1,763

 

 
1,763

 

Non-interest bearing deposits
5,642,751

 
5,642,751

 

 
5,642,751

 

Interest bearing deposits
15,234,039

 
15,244,020

 

 
15,244,020

 

Federal funds purchased and securities sold under repurchase agreements
148,132

 
148,132

 
148,132

 

 

Salary stock units
1,764

 
1,764

 
1,764

 

 

Long-term debt
2,033,141

 
2,095,720

 

 
2,095,720

 

Derivative liabilities
$
42,142

 
42,142

 

 
39,436

 
2,706